Mitos Therapeutics is a biotech venture company developing innovative mitochondrial-based therapeutics for cancer and metabolic syndrome, with a primary focus on creating a treatment for age-related sarcopenia. In particular, we have entered the lead optimization stage with candidate compounds targeting a novel target, PHF20, aiming to deliver effective therapies for the rapidly growing global population affected by sarcopenia.

Treatment of Sarcopenia